medonline · 6 years ago
Am 15. März startet der Kongress der European Association of Urology in Barcelona. Hier ist ein Ausblick auf die kommenden Highlights. (Für Ärzte) #EAU19 https://t.co/C7ERVqjh9Z
Am 15. März startet der Kongress der European Association of Urology in Barcelona. Hier ist ein Ausblick auf die kommenden Highlights. (Für Ärzte) #EAU19 https://t.co/C7ERVqjh9Z
Additional clinical support for IceCure’s #ProSense cryoablation technology will be presented at #EAU19 tomorrow, 15 March. If you’re at the conference be sure to catch this presentation. https://t.co/uIPjSopY2m
Clinical support for IceCure’s #ProSense #cryoablation technology at #EAU19 tomorrow, 15 March. If you’re at the conference be sure to catch Expert-Guided Poster Tour PT060 with Dr. Sagi Shprits #cryotherapy #ProSense #cryogenics #cancertreatment https://t.co/fiDVjTxHiD https://t.co/KPL62gbXiB
CAMINO AL #EAU19 DE @Uroweb EN BARCELONA Y A DISERTAR EN LAS JORNADAS QUIRÚRGICAS HOLEP/LITIASIS DE @ImqEuskadi EN BILBAO ??.
Muy agradecido por la posibilidad de exponer acerca de la cirugía de litiasis con grandes profesionales, entre ellos, mi amigo @GasparIbarluzea ?. https://t.co/IW1Z9rdUCd
Ready for a real challenge? Here’s sneak peek of a “moderate” level question for the I-O Challenge at booth E50 at #EAU19. Will this give you the head start you need to succeed?
Which of the following is NOT a contraindication to systemic checkpoint blockade? https://t.co/AJ51zTBDGo
Join us @EAU show. This coming Saturday, Booth G59. #ED1000 #ESWL
#EM1000 #EAU19 #Medispec #Shockwavetherapy https://t.co/tuaEMrJmb1
? For those staying at home: We will broadcast the #EAU19 opening ceremony live via Facebook!
Use the button to get a notification when the broadcast starts on Friday:
▶️ https://t.co/kDakRzA9O9 https://t.co/UPrq2SJzmj
#EAU19 ready to go! #BCN
# don’t forget your poster at home! https://t.co/cyBcDH7SdE
IAU workshop pre #EAU19 at @hospitalclinic led by @JmLopezMartnz . Live supine PCNL https://t.co/Qo5hH0kOcR
Breaking News: Phase-IIIb-Studie SAUL, Wirksamkeit und Sicherheit des PD-L1-Inhibitors Atezolizumab beim mBCa in Zweit- bis Viertlinie (Plenary Session 5, 18.3., 7.30–8.00 Uhr) #EAU19 #UroSoMe
@DGUrologie
@amerseburger @AStenzl @BDUrologie @DGUrologie @lusuardi_lukas @wulfingc
On my way to Barcelona, #EAU19 #UroSoMe https://t.co/52mc01oW1J